There have been 50 recent insider transactions recorded for CERo Therapeutics Holdings, Inc. (CERO), including 31 buys and 13 sells. Total insider buying was valued at $5.26M and total insider selling at $4.51M.
Notable insiders with recent activity include Laporte Kathleen, Atwood Brian G, Ehrlich Christopher B. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — CERO
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2025-05-30 |
Laporte Kathleen |
Director |
RSU Award |
9,326 |
$0.45 |
$4.15K |
9,326 |
| 2025-05-30 |
Atwood Brian G |
Director |
RSU Award |
122,549 |
$0.45 |
$54.58K |
122,549 |
| 2025-05-30 |
Ehrlich Christopher B |
Chairman and CEO |
RSU Award |
61,843 |
$0.45 |
$27.54K |
61,842 |
| 2025-05-30 |
Patel Shami |
Director |
RSU Award |
11,693 |
$0.45 |
$5.21K |
11,693 |
| 2025-05-30 |
Byrnes Michael |
Director |
RSU Award |
9,326 |
$0.45 |
$4.15K |
9,326 |
| 2025-05-30 |
Rolfe Lindsey |
Director |
RSU Award |
9,326 |
$0.45 |
$4.15K |
9,326 |
| 2025-05-30 |
Kucharchuk Andrew Albert |
Chief Financial Officer |
RSU Award |
152,500 |
$0.45 |
$67.92K |
152,500 |
| 2025-05-30 |
Pierce Kristen |
Chief Development Officer |
RSU Award |
154,841 |
$0.45 |
$68.97K |
154,841 |
| 2025-03-31 |
Atwood Brian G |
Director |
Option Exercise |
294,460 |
$0.00 |
$29.45 |
11,660 |
| 2025-03-04 |
Ehrlich Christopher B |
Chairman and CEO |
RSU Award |
119,486 |
$1.43 |
$170.86K |
119,486 |
| 2025-02-24 |
Laporte Kathleen |
Director |
RSU Award |
127,500 |
$0.10 |
$12.75K |
255,000 |
| 2025-02-24 |
Atwood Brian G |
Director |
RSU Award |
254,000 |
$0.10 |
$25.4K |
508,000 |
| 2025-02-24 |
Ehrlich Christopher B |
Chairman and CEO |
RSU Award |
1,275,000 |
$0.10 |
$127.5K |
2,550,000 |
| 2025-02-24 |
Patel Shami |
Director |
RSU Award |
127,500 |
$0.10 |
$12.13K |
255,000 |
| 2025-02-24 |
Byrnes Michael |
Director |
RSU Award |
127,500 |
$0.10 |
$12.75K |
255,000 |
| 2025-02-24 |
Rolfe Lindsey |
Director |
RSU Award |
127,500 |
$0.10 |
$12.75K |
255,000 |
| 2025-02-07 |
Atwood Brian G |
Director |
RSU Award |
204,080 |
$1.96 |
$400K |
204,080 |
| 2024-12-13 |
Yk Bioventures Opportunities Gp I, Llc |
10 Percent Owner |
Informative Sell |
2,998,908 |
$0.06 |
$179.93K |
13,005,169 |
| 2024-12-12 |
Yk Bioventures Opportunities Gp I, Llc |
10 Percent Owner |
Informative Sell |
1,614,541 |
$0.07 |
$113.02K |
16,004,077 |
| 2024-12-11 |
Yk Bioventures Opportunities Gp I, Llc |
10 Percent Owner |
Informative Sell |
1,343,801 |
$0.08 |
$107.5K |
17,618,618 |
| 2024-12-10 |
Yk Bioventures Opportunities Gp I, Llc |
10 Percent Owner |
Informative Sell |
1,570,947 |
$0.09 |
$141.39K |
18,962,419 |
| 2024-12-09 |
Yk Bioventures Opportunities Gp I, Llc |
10 Percent Owner |
Informative Sell |
850,543 |
$0.11 |
$93.56K |
20,533,366 |
| 2024-12-06 |
Yk Bioventures Opportunities Gp I, Llc |
10 Percent Owner |
Informative Sell |
1,236,874 |
$0.12 |
$148.42K |
21,383,909 |
| 2024-12-02 |
Laporte Kathleen |
Director |
RSU Award |
127,500 |
$0.10 |
$12.75K |
127,500 |
| 2024-12-02 |
Atwood Brian G |
Director |
RSU Award |
254,000 |
$0.10 |
$25.4K |
254,000 |
| 2024-12-02 |
Ehrlich Christopher B |
Chairman and CEO |
RSU Award |
1,275,000 |
$0.10 |
$127.5K |
1,275,000 |
| 2024-12-02 |
Patel Shami |
Director |
RSU Award |
127,500 |
$0.10 |
$12.13K |
127,500 |
| 2024-12-02 |
Byrnes Michael |
Director |
RSU Award |
127,500 |
$0.10 |
$12.75K |
127,500 |
| 2024-12-02 |
Rolfe Lindsey |
Director |
RSU Award |
127,500 |
$0.10 |
$12.75K |
127,500 |
| 2024-10-11 |
Patel Shami |
Director |
Unknown |
- |
- |
- |
110,000 |
| 2024-10-10 |
Yk Bioventures Opportunities Gp I, Llc |
10 Percent Owner |
Informative Sell |
3,250,000 |
$0.10 |
$325K |
22,620,783 |
| 2024-10-01 |
Kucharchuk Andrew Albert |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-10-01 |
Kucharchuk Andrew Albert |
Chief Financial Officer |
RSU Award |
500,000 |
$0.10 |
$50K |
500,000 |
| 2024-10-01 |
Pierce Kristen |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-10-01 |
Pierce Kristen |
Chief Development Officer |
RSU Award |
200,000 |
$0.10 |
$20K |
200,000 |
| 2024-10-01 |
Pierce Kristen |
Chief Development Officer |
Unknown |
659 |
$10.00 |
$6.59K |
- |
| 2024-09-30 |
Atwood Brian G |
Director |
Return of Shares |
1,317,956 |
$1.77 |
$2.33M |
- |
| 2024-09-30 |
Ehrlich Christopher B |
Interim Chairman and CEO |
Return of Shares |
572,182 |
$1.77 |
$1.01M |
- |
| 2024-09-26 |
Yk Bioventures Opportunities Gp I, Llc |
10 Percent Owner |
Unknown |
- |
- |
- |
25,870,783 |
| 2024-09-25 |
Laporte Kathleen |
Director |
Option Exercise (Sell) |
50 |
- |
- |
- |
| 2024-09-25 |
Atwood Brian G |
Director |
Option Exercise (Sell) |
1,002 |
- |
- |
- |
| 2024-09-25 |
Ehrlich Christopher B |
Interim Chairman and CEO |
Option Exercise (Sell) |
275 |
- |
- |
- |
| 2024-09-25 |
Sloan Stuart M |
10 Percent Owner |
Informative Sell |
532,486 |
$0.10 |
$55.54K |
21,067,956 |
| 2024-09-24 |
Sloan Stuart M |
10 Percent Owner |
Unknown |
- |
- |
- |
21,600,442 |
| 2024-06-28 |
Carter Charles Ross |
Chief Financial Officer |
RSU Award |
100,000 |
$0.30 |
$30K |
100,000 |
| 2024-03-25 |
Laporte Kathleen |
Director |
RSU Award |
112,500 |
$1.77 |
$199.13K |
112,500 |
| 2024-03-25 |
Atwood Brian G |
Chief Executive Officer |
RSU Award |
1,317,956 |
$1.77 |
$2.33M |
1,317,956 |
| 2024-03-25 |
Ehrlich Christopher B |
Director |
RSU Award |
572,182 |
$1.77 |
$1.01M |
572,182 |
| 2024-03-25 |
Byrnes Michael |
Director |
RSU Award |
112,500 |
$1.77 |
$199.13K |
112,500 |
| 2024-03-25 |
Rolfe Lindsey |
Director |
RSU Award |
112,500 |
$1.77 |
$199.13K |
112,500 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
